Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Esophageal adenocarcinoma carries a poor prognosis and therefore treatment of early neoplasia arising in the precursor condition Barrett’s esophagus (BE) is desirable. Visible lesions arising in BE need endoscopic mucosal resection for accurate staging and removal. Resection modalities include a cap-based system with snare and custom-made multiband mucosectomy (MBM) devices (Duette, Cook Medical Ltd). A new MBM device has recently become available (Captivator, Boston Scientific Ltd).
A retrospective pilot study to compare the efficacy, safety, specimen size and histology of endoscopic mucosal resection (EMR) specimens resected with two MBM devices (Cook Duette and Boston Captivator) in treatment naive patients undergoing endoscopic therapy for BE neoplasia.
Consecutive EMR procedures carried out by a single experienced endoscopist were analysed. All visible lesions were marked and resected using one of the two MBM devices. All resected specimens were analysed by the same two experienced pathologists. The resected specimens in both groups were analysed for maximum diameter, minimum diameter, surface area and depth.
Twenty consecutive patients were analysed (18M + 2F; mean age 74) in the Duette group and 20 (17M + 3F; mean age 72) in the Captivator group. A total of 58 specimens were resected in the Duette and 63 in the Captivator group. Min diameter, max diameter, surface area and depth of the ER specimens resected by the Captivator device were significantly larger than that by the Duette device [min diameter 9.89 mm vs 9.07 mm (p = 0.019); max diameter: 13.54 mm vs 12.38 mm (p = 0.024); surface area: 135.40 mm2 vs 113.89 mm2 (p = 0.005); depth 3.71 mm vs 2.89 (p = 0.001)].
These two MBM devices showed equivalent efficacy and safety outcomes, but the EMR Captivator device resected specimens with a larger area in the esophagus when compared with the Duette device. A possible advantage of this is in situations where en bloc resections with fewer EMRs are desirable for larger lesions.
Spechler SJ (2002) Barrett’s esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy. Med Clin N Am 86:1423–1445 CrossRef
Fernando HC, Murthy SC, Hofstetter W, Shrager JB, Bridges C, Mitchell JD et al (2009) The Society of Thoracic Surgeons Practice guideline series: guidelines for the management of Barrett’s esophagus with high-grade dysplasia. Ann Thorac Surg 87:1993–2002 CrossRef
Prasad G, Wang K, Buttar N, Wongkeesong L, Krishnadath K, Nichols F, Lutzke L, Borkenhagen LS (2007) Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 132:1226–1233 CrossRef
Stein HJ, Hutter J, Feith M, von Rahden BHA (2007) Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus. Semin Thorac Cardiovasc Surg 19:72–78 CrossRef
Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P et al (2014) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 63:7–42 CrossRef
Weusten B, Bisschops R, Coron E, Dinis-Ribeiro M, Dumonceau J-M, Esteban J-M et al (2017) Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy 49:1–8 CrossRef
Shimada H, Nabeya Y, Matsubara H, Okazumi SI, Shiratori T, Shimizu T et al (2006) Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg 191:250–254 CrossRef
Peters FP, Kara MA, Rosmolen WD, Aalders MCG, Ten Kate FJW, Bultje BC et al (2005) Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc 61:506–514 CrossRef
Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M et al (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146:652–660.e1 CrossRef
Rice T, Falk G, Achkar EPR (1993) Surgical management of high-grade dysplasia in Barrett’s esophagus. Am J Gastroenterol 88:1832–1836 PubMed
Inoue H, Takeshita K, Hori H, Muraoka Y, Yoneshima H, Endo M (1993) Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 39:58–62 CrossRef
Pouw RE, Van Vilsteren FGI, Peters FP, Herrero LA, Ten Kate FJW, Visser M et al (2011) Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc 74:35–43 CrossRef
Eluri S, Shaheen NJ (2017) Barrett’s esophagus: diagnosis and management. Gastrointest Endosc 85:889–903 CrossRef
Cook Medical. Duette® Multi-Band Mucosectomy. 2018. https://www.cookmedical.com/products/esc_duette_webds/. cited Accessed 29 Mar 2018
Alvarez Herrero L, Pouw RE, Van Vilsteren FGI, Ten Kate FJW, Visser M, Seldenrijk CA et al (2011) Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett’s esophagus. Endoscopy 43:177–183 CrossRef
Schölvinck DW, Belghazi K, Pouw RE, Curvers WL, Weusten BLaM, Bergman JJGHM (2015) In vitro assessment of the performance of a new multiband mucosectomy device for endoscopic resection of early upper gastrointestinal neoplasia. Surg Endosc 30:471–479 CrossRef
Participants in the paris work shop (2003) The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 58:3–43
Vahabzadeh B, Seetharam AB, Cook MB, Wani S, Rastogi A, Bansal A et al (2015) Validation of the Prague C&M criteria for the endoscopic grading of Barrett’s esophagus among gastroenterology trainees: a multicenter study. Gastrointest Endosc 75(2):236–241 CrossRef
Hamilton RH, Aaltonen LA (2000) WHO classification of tumours, pathology and genetics of tumours of the digestive system. IARC Press, Lyon
Bhat S, Coleman HG, Yousef F, Johnston BT, McManus DT, Gavin AT et al (2011) Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst 103:1049–1057 CrossRef
Desai M, Saligram S, Gupta N, Vennalaganti P, Bansal A, Choudhary A et al (2017) Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett’s esophagus-related neoplasia: a systematic review and pooled analysis. Gastrointest Endosc 85:482–495 CrossRef
Tomizawa Y, Konda VJA, Coronel E, Chapman CG, Siddiqui UD (2017) Efficacy, durability, and safety of complete endoscopic mucosal resection of Barrett esophagus: a systematic review and meta-analysis. J Clin Gastroenterol 52(3):210–216
Peters FP, Kara MA, Curvers WL, Rosmolen WD, Fockens P, Krishnadath KK, Ten Kate FJ, Bergman JJ (2007) Multiband mucosectomy for endoscopic resection of Barrett’s esophagus: feasibility study with matched historical controls. Eur J Gastroenterol Hepatol 19:311–315 CrossRef
Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL et al (2015) Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett’s oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut 64:1192–1199 CrossRef
Matsuzaki K, Nagao S, Kawaguchi A, Miyazaki J, Yoshida Y, Kitagawa Y et al (2003) Newly designed soft prelooped cap for endoscopic mucosal resection of gastric lesions. Gastrointest Endosc 57:242–246 CrossRef
Manner H, Pech O, Heldmann Y, May A, Pohl J, Behrens A et al (2013) Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 11:630–635 CrossRef
Crane SJ, Locke GR, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ (2008) Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc 83:1087–1094 CrossRef
Pouw RE, Wirths K, Eisendrath P, Sondermeijer CM, Ten Kate FJ, Fockens P et al (2010) Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol 8:23–29 CrossRef
- Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett’s esophagus-related neoplasia
Laurence B. Lovat
- Springer US
Neu im Fachgebiet Chirurgie
Mail Icon II